Nonmuscle myosin light chain kinase activity modulates radiation-induced lung injury.
Rizzo, Alicia N
Dudek, Steven M
Weichselbaum, Ralph R
Jacobson, Jeffrey R
Garcia, Joe G N
MetadataShow full item record
CitationNonmuscle myosin light chain kinase activity modulates radiation-induced lung injury. 2016, 6 (2):234-9 Pulm Circ
Rights© 2016 by the Pulmonary Vascular Research Institute. All rights reserved.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractRadiotherapy as a primary treatment for thoracic malignancies induces deleterious effects, such as acute or subacute radiation-induced lung injury (RILI). Although the molecular etiology of RILI is controversial and likely multifactorial, a potentially important cellular target is the lung endothelial cytoskeleton that regulates paracellular gap formation and the influx of macromolecules and fluid to the alveolar space. Here we investigate the central role of a key endothelial cytoskeletal regulatory protein, the nonmuscle isoform of myosin light chain kinase (nmMLCK), in an established murine RILI model. Our results indicate that thoracic irradiation significantly augmented nmMLCK protein expression and enzymatic activity in murine lungs. Furthermore, genetically engineered mice harboring a deletion of the nmMLCK gene (nmMLCK(-/-) mice) exhibited protection from RILI, as assessed by attenuated vascular leakage and leukocyte infiltration. In addition, irradiated wild-type mice treated with two distinct MLCK enzymatic inhibitors, ML-7 and PIK (peptide inhibitor of kinase), also demonstrated attenuated RILI. Taken together, these data suggests a key role for nmMLCK in vascular barrier regulation in RILI and warrants further examination of RILI strategies that target nmMLCK.
NoteElectronically published April 19, 2016. 12 month embargo.
VersionFinal published version
- Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury.
- Authors: Mirzapoiazova T, Moitra J, Moreno-Vinasco L, Sammani S, Turner JR, Chiang ET, Evenoski C, Wang T, Singleton PA, Huang Y, Lussier YA, Watterson DM, Dudek SM, Garcia JG
- Issue date: 2011 Jan
- Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration.
- Authors: Sun C, Wu MH, Yuan SY
- Issue date: 2011 Jul 5
- Proline-rich region of non-muscle myosin light chain kinase modulates kinase activity and endothelial cytoskeletal dynamics.
- Authors: Belvitch P, Adyshev D, Elangovan VR, Brown ME, Naureckas C, Rizzo AN, Siegler JH, Garcia JG, Dudek SM
- Issue date: 2014 Sep
- Nonmuscle myosin light chain kinase regulates murine asthmatic inflammation.
- Authors: Wang T, Moreno-Vinasco L, Ma SF, Zhou T, Shimizu Y, Sammani S, Epshtein Y, Watterson DM, Dudek SM, Garcia JG
- Issue date: 2014 Jun
- Sp1-mediated nonmuscle myosin light chain kinase expression and enhanced activity in vascular endothelial growth factor-induced vascular permeability.
- Authors: Shimizu Y, Camp SM, Sun X, Zhou T, Wang T, Garcia JG
- Issue date: 2015 Dec